These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16101450)

  • 1. Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.
    Bryan J; Crane A; Vila-Carriles WH; Babenko AP; Aguilar-Bryan L
    Curr Pharm Des; 2005; 11(21):2699-716. PubMed ID: 16101450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KATP channel openers: structure-activity relationships and therapeutic potential.
    Mannhold R
    Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.
    Jin JY; Park SH; Bae JH; Cho HC; Lim JG; Park WS; Han J; Lee JH; Song DK
    Pharmacol Res; 2007 Sep; 56(3):237-47. PubMed ID: 17656102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.
    Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ
    Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids modulate ligand binding to sulphonylurea receptors.
    Klein A; Lichtenberg J; Stephan D; Quast U
    Br J Pharmacol; 2005 Aug; 145(7):907-15. PubMed ID: 15895108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.
    Gribble FM; Reimann F
    J Diabetes Complications; 2003; 17(2 Suppl):11-5. PubMed ID: 12623163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.
    Hambrock A; de Oliveira Franz CB; Hiller S; Grenz A; Ackermann S; Schulze DU; Drews G; Osswald H
    J Biol Chem; 2007 Feb; 282(5):3347-56. PubMed ID: 17138562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonylurea stimulation of insulin secretion.
    Proks P; Reimann F; Green N; Gribble F; Ashcroft F
    Diabetes; 2002 Dec; 51 Suppl 3():S368-76. PubMed ID: 12475777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.
    Nagashima K; Takahashi A; Ikeda H; Hamasaki A; Kuwamura N; Yamada Y; Seino Y
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S75-8. PubMed ID: 15563985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and distribution of the SUR isoforms and splice variants.
    Shi NQ; Ye B; Makielski JC
    J Mol Cell Cardiol; 2005 Jul; 39(1):51-60. PubMed ID: 15978902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylurea receptors and mechanism of sulfonylurea action.
    Panten U; Schwanstecher M; Schwanstecher C
    Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.
    Babenko AP
    J Biol Chem; 2008 Apr; 283(14):8778-82. PubMed ID: 18281290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine triphosphate-sensitive potassium (K(ATP)) channel activity is coupled with insulin resistance in obesity and type 2 diabetes mellitus.
    Wasada T
    Intern Med; 2002 Feb; 41(2):84-90. PubMed ID: 11868613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
    Hosy E; Dérand R; Revilloud J; Vivaudou M
    J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular basis of oral hypoglycemic sulfonylurea action].
    Owecki M; Horst-Sikorska W; Sowiński J
    Pol Merkur Lekarski; 2003 Nov; 15(89):445-8. PubMed ID: 14969140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylurea receptors, ion channels, and fruit flies.
    Boyd AE
    Diabetes; 1988 Jul; 37(7):847-50. PubMed ID: 2454858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of sulfonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium.
    Lovasz N; Ducza E; Gaspar R; Falkay G
    Reproduction; 2011 Jul; 142(1):175-81. PubMed ID: 21527399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.